menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Biosight Launches a Phase 1/2 Trial of Aspacytarabine with Venetoclax

    PRNEWSWIRE

    Biosight Granted ODD from FDA for Aspacytarabine for Myelodysplastic Syndromes

    PRNEWSWIRE

    Biosight Shows Final Primary Endpoint Data from Phase 2b Study of BST-236 in AML

    GLOBENEWSWIRE

    Biosight Initiates Phase 2 Clinical Trial of Aspacytarabine for MDS and AML

    GLOBENEWSWIRE

    Biosight Announces Initiation of Phase 2 Clinical Trial of Aspacytarabine

    GLOBENEWSWIRE

    Advaxis and Biosight Announce Entry into Definitive Merger Agreement

    GLOBENEWSWIRE

    Biosight to Present Updated Clinical Data from Ongoing Ph 2b Study of (BST-236)

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.